VGLL3 anticorps (Biotin)

N° du produit ABIN1401325

Détail du produit anti-VGLL3 anticorps (Biotin)

Antigène: VGLL3 (Vestigial Like 3 (VGLL3))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp VGLL3 est conjugé à/à la Biotin

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human VGLL3

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur VGLL3

Antigène: VGLL3 (Vestigial Like 3 (VGLL3))

Autre désignation: VGLL3 (VGLL3 Produits)

Synonymes: anticorps RGD1560030, anticorps VGL-3, anticorps VGL3, anticorps 1700110N18Rik, anticorps 4832416J22, anticorps C80713, anticorps Vgl-3, anticorps Vito-2, anticorps vestigial-like family member 3, anticorps vestigial like family member 3, anticorps Vgll3, anticorps VGLL3

Sujet:

Synonyms: Colon carcinoma related protein, Vestigial like 3 Drosophila, VGL 3, VGL-3, VGL3, VGLL3_HUMAN.

Background: The transcriptional enhancer factor-1 (TEF-1) family of transcription factors regulate tissue-specific gene expression in muscle and placenta. The mechanism whereby TEF-1 confers tissue specificity depends largely on the interaction of TEF-1 with tissue-specific cofactors. Transcription cofactor Vgl-3 (vestigial-like protein 3), also known as colon carcinoma related protein, is a 326 amino acid nuclear protein that may act as a specific coactivator for the mammalian transcription elongation factors. Both Vgl-1 and Vgl-3 are enriched in placenta, whereas Vgl-2 is expressed in differentiating somites and branchial arches during embryogenesis and is skeletal-muscle specific in adult tissues. There are two isoforms of Vgl-3 that are produced as a result of alternative splicing events.

ID gène: 389136